Clinical Trial

Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a prospective, open-label, multicenter long-term follow-up study to evaluate the durability of virologic response in subjects with chronic hepatitis B previously treated with AHB-137 injection.
Protocol Amendment History 1 change
notable Trial sites expanded: 2 -> 8 locations 2026-07-30
Trial Details
NCT Number NCT07146100
Lead Sponsor Ausper Biopharma Co., Ltd.
Conditions Chronic Hepatitis B
Enrollment 200 participants
Start Date 2025-08-28
Primary Completion 2028-01-01 (estimated)
Study Completion 2030-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-29